Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelins and asthma.

R G Goldie1, P J Henry

  • 1Department of Pharmacology, University of Western Australia, Perth, Nedlands, Australia. rgoldie@receptor.pharm.uwa.edu.au

Life Sciences
|July 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Sexuality-as-Gendered Framework From Interpersonal Contact.

Personality & social psychology bulletin·2025
Same author

Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosis.

Clinical radiology·2024
Same author

The Relationship Between Gender and Sexual Orientation in Academia.

Journal of homosexuality·2023
Same author

Regional Measures of Sexual-Orientation Bias Predict Where Same-Gender Couples Live.

Psychological science·2023
Same author

LGBT workplace protections as an extension of the protected class framework.

Law and human behavior·2020
Same author

Gender inequality and gender differences in authoritarianism.

Personality & social psychology bulletin·2012
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Endothelin-1 (ET-1) is a potent airway smooth muscle spasmogen implicated in asthma. Evidence suggests ET-1 plays a mediator role in this obstructive respiratory disease, though a direct causal link is not yet established.

Area of Science:

  • Pulmonary Medicine
  • Cardiovascular Research
  • Respiratory Pharmacology

Background:

  • Endothelin-1 (ET-1) identified as a vascular endothelium-derived spasmogen with roles in vascular diseases.
  • Growing evidence suggests ET-1's involvement as a mediator in obstructive respiratory diseases, particularly asthma.
  • ET-1 is a potent spasmogen in airway smooth muscle and is produced by bronchial epithelium.

Purpose of the Study:

  • To review and synthesize evidence supporting the potential mediator roles of ET-1 in asthma.
  • To examine the link between ET-1 activity and asthma pathophysiology.
  • To discuss the impact of anti-inflammatory treatments on ET-1 indices in asthmatics.

Main Methods:

  • Review of existing scientific literature on endothelin-1 and asthma.

Related Experiment Videos

  • Analysis of studies investigating ET-1's effects on airway smooth muscle.
  • Examination of research on ET-1 synthesis and release in the bronchial epithelium.
  • Evaluation of data from asthmatic patients and the effects of glucocorticoid treatment.

    • Main Results:

    • ET-1 demonstrates potent spasmogenic activity in human and animal airway smooth muscle.
    • ET-1 is synthesized and released from the bronchial epithelium.
    • Asthmatic patients show enhanced ET-1 activity, which is reduced by glucocorticoid treatment.
    • A definitive causal link between ET-1 and asthma remains to be definitively established.

    Conclusions:

    • Significant evidence suggests endothelin-1 (ET-1) has a potential mediator role in asthma.
    • Elevated ET-1 activity in symptomatic asthma is reduced by anti-inflammatory glucocorticoids.
    • Further research is needed to definitively establish a causal link between ET-1 and asthma pathophysiology.